Hims & Hers Health, Inc. (HIMS)

NYQ – Real Time Price. Currency in USD

29.98

-0.53 (-1.74%)

At close: Aug 12, 2026, 3:59 PM EDT

29.90

-0.07 (-0.23%)

After-hours: Aug 12, 2026, 4:38 PM EDT

12.08.2026

Hims & Hers: The Guidance Raise Doesn't Fix The Margin Problem

Hims & Hers Health delivered strong Q2 2026 revenue growth but suffered margin compression and negative free cash flow. I rate HIMS a Sell, as the raised revenue guidance is offset by declining gross margins and a stagnant adjusted EBITDA outlook. The shift to branded GLP-1 weight-loss drugs and international expansion are driving higher costs and complicating the profitability story.

11.08.2026

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg, P.C. (“Lowey”) announces that it filed the first class action complaint against Hims & Hers Health, Inc. (“Hims & Hers”) on behalf of consumers of the Hims & Hers telehealth platforms—one day after the Federal Trade Commission (“FTC”), joined by the People of the State of California and the Utah Division of Consumer Protection, filed its civil enforcement action against the company.

11.08.2026

Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down

HIMS posts a wider-than-expected loss and weaker gross margin in second-quarter 2026 despite strong revenue growth and a raised full-year outlook.

11.08.2026

Hims & Hers Q2 revenue beat offset by wider-than-expected loss

Hims & Hers Health (NYSE:HIMS) delivered mixed second-quarter results, with revenue beating Wall Street expectations while its quarterly loss came in wider than analysts had forecast as the company incurred restructuring charges tied to its shift toward branded GLP-1 weight-loss options. Revenue for the quarter ended June 30 rose 38% year over year to $753.2 million, topping the roughly $699 million analysts had expected.

11.08.2026

HIMS Q2 Earnings Call Focuses on AI and Global Expansion

Hims & Hers raises its 2026 revenue outlook as AI boosts engagement, specialty care expands and Eucalyptus extends its international reach despite margin pressure.

11.08.2026

Tuesday's Morning Movers: RKLB & HIMS Earnings, RIOT Gets Anthropic Deal

Hims & Hers (HIMS) shares struggled to find their footing after the company posted a quarterly loss despite seeing revenue and guidance rise. Sam Vadas discusses the earnings and the price action following the report.

11.08.2026

Kaplan Fox Alerts Hims & Hers Health, Inc. (HIMS) Investors to an Investigation of Potential Securities Law Violations

New York, New York--(Newsfile Corp. - August 11, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Hims & Hers investor and have suffered losses, or if you have information that could assist in the Hims & Hers investigation, you may CLICK HERE to contact us.

Videos

11.08.2026

Negative

Tuesday's Morning Movers: RKLB & HIMS Earnings, RIOT Gets Anthropic Deal

10.08.2026

Positive

Raul Shah on HIMS Earnings Expectations & GLP-1 Wave's Lasting Stock Impacts

03.08.2026

Positive

Market Matters Ep. 12: How HIMS Could Benefit From FDA Changes

Press releases

11.08.2026

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

11.08.2026

Kaplan Fox Alerts Hims & Hers Health, Inc. (HIMS) Investors to an Investigation of Potential Securities Law Violations

10.08.2026

Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading global health and wellness platform, today announced financial results for the second quarter ended June 30, 2026. “Hims & Hers is delivering a world-class health experience at a global scale and a reasonable price for the nearly 3 million people who rely on us for access to care. We're proving, quarter after quarter, that helping people feel great and delivering strong.

10.08.2026

HIMS & HERS HEALTH, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Hims & Hers Health, Inc.'s Directors and Officers for Breach of Fiduciary Duties – HIMS

NEW YORK--(BUSINESS WIRE)---- $HIMS #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Hims & Hers Health, Inc. (NYSE: HIMS) failed to manage Hims & Hers in an acceptable manner, breaching their fiduciary duties to Hims & Hers, and whether Hims & Hers and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On July 29, 2026, the Federa.

Hims & Hers Health, Inc. (HIMS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Hims & Hers Health, Inc. (HIMS)

Hims & Hers: The Guidance Raise Doesn't Fix The Margin Problem

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down

Hims & Hers Q2 revenue beat offset by wider-than-expected loss

HIMS Q2 Earnings Call Focuses on AI and Global Expansion

Tuesday's Morning Movers: RKLB & HIMS Earnings, RIOT Gets Anthropic Deal

Kaplan Fox Alerts Hims & Hers Health, Inc. (HIMS) Investors to an Investigation of Potential Securities Law Violations

Videos

Press releases

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

Kaplan Fox Alerts Hims & Hers Health, Inc. (HIMS) Investors to an Investigation of Potential Securities Law Violations

Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results

HIMS & HERS HEALTH, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Hims & Hers Health, Inc.'s Directors and Officers for Breach of Fiduciary Duties – HIMS

Hims & Hers: The Guidance Raise Doesn't Fix The Margin Problem

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down

Hims & Hers Q2 revenue beat offset by wider-than-expected loss

HIMS Q2 Earnings Call Focuses on AI and Global Expansion

Tuesday's Morning Movers: RKLB & HIMS Earnings, RIOT Gets Anthropic Deal

Kaplan Fox Alerts Hims & Hers Health, Inc. (HIMS) Investors to an Investigation of Potential Securities Law Violations

Videos

Press releases

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

Kaplan Fox Alerts Hims & Hers Health, Inc. (HIMS) Investors to an Investigation of Potential Securities Law Violations

Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results

HIMS & HERS HEALTH, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Hims & Hers Health, Inc.'s Directors and Officers for Breach of Fiduciary Duties – HIMS

Search stocks

Hims & Hers Health, Inc. (HIMS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Hims & Hers Health, Inc. (HIMS)

Hims & Hers: The Guidance Raise Doesn't Fix The Margin Problem

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down

Hims & Hers Q2 revenue beat offset by wider-than-expected loss

HIMS Q2 Earnings Call Focuses on AI and Global Expansion

Tuesday's Morning Movers: RKLB & HIMS Earnings, RIOT Gets Anthropic Deal

Kaplan Fox Alerts Hims & Hers Health, Inc. (HIMS) Investors to an Investigation of Potential Securities Law Violations

Videos

Press releases

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

Kaplan Fox Alerts Hims & Hers Health, Inc. (HIMS) Investors to an Investigation of Potential Securities Law Violations

Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results

HIMS & HERS HEALTH, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Hims & Hers Health, Inc.'s Directors and Officers for Breach of Fiduciary Duties – HIMS

Hims & Hers: The Guidance Raise Doesn't Fix The Margin Problem

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down

Hims & Hers Q2 revenue beat offset by wider-than-expected loss

HIMS Q2 Earnings Call Focuses on AI and Global Expansion

Tuesday's Morning Movers: RKLB & HIMS Earnings, RIOT Gets Anthropic Deal

Kaplan Fox Alerts Hims & Hers Health, Inc. (HIMS) Investors to an Investigation of Potential Securities Law Violations

Videos

Press releases

FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class Action Complaint on Behalf of Consumers

Kaplan Fox Alerts Hims & Hers Health, Inc. (HIMS) Investors to an Investigation of Potential Securities Law Violations

Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results

HIMS & HERS HEALTH, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Hims & Hers Health, Inc.'s Directors and Officers for Breach of Fiduciary Duties – HIMS